Megumi Sawada

681 total citations
17 papers, 535 citations indexed

About

Megumi Sawada is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Megumi Sawada has authored 17 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in Megumi Sawada's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). Megumi Sawada is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). Megumi Sawada collaborates with scholars based in Japan and United States. Megumi Sawada's co-authors include Yasuyuki Yoshizawa, Yoshio Ohtani, Naohiko Inase, Shinichi Ohdama, Shuji Miyake, Y Yoshizawa, S. Miyake, Yasunari Miyazaki, Yuki Sumi and Kaoru Kojima and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and British Journal of Cancer.

In The Last Decade

Megumi Sawada

16 papers receiving 523 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Megumi Sawada Japan 9 277 149 77 76 70 17 535
I. Birgitta Sundell United States 11 197 0.7× 217 1.5× 113 1.5× 36 0.5× 36 0.5× 25 657
Ken Kaito Japan 10 82 0.3× 358 2.4× 34 0.4× 27 0.4× 57 0.8× 45 584
Celso Arrais‐Rodrigues Brazil 12 64 0.2× 225 1.5× 58 0.8× 56 0.7× 36 0.5× 56 492
Y Tüzün Türkiye 18 849 3.1× 130 0.9× 193 2.5× 42 0.6× 94 1.3× 28 2.0k
Irina Zaidman Israel 13 65 0.2× 146 1.0× 71 0.9× 41 0.5× 97 1.4× 47 438
Miguel Jiménez-Alcázar Germany 9 126 0.5× 118 0.8× 84 1.1× 53 0.7× 249 3.6× 10 803
J. Phillips United Kingdom 11 57 0.2× 272 1.8× 52 0.7× 22 0.3× 55 0.8× 23 605
Scott C. Meixner Canada 8 101 0.4× 143 1.0× 42 0.5× 10 0.1× 51 0.7× 12 381
A Farkas Hungary 9 100 0.4× 99 0.7× 52 0.7× 14 0.2× 94 1.3× 26 525
Xiaoduan Weng Canada 11 95 0.3× 39 0.3× 48 0.6× 18 0.2× 70 1.0× 22 431

Countries citing papers authored by Megumi Sawada

Since Specialization
Citations

This map shows the geographic impact of Megumi Sawada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megumi Sawada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megumi Sawada more than expected).

Fields of papers citing papers by Megumi Sawada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megumi Sawada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megumi Sawada. The network helps show where Megumi Sawada may publish in the future.

Co-authorship network of co-authors of Megumi Sawada

This figure shows the co-authorship network connecting the top 25 collaborators of Megumi Sawada. A scholar is included among the top collaborators of Megumi Sawada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megumi Sawada. Megumi Sawada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Nishio, Miwako, et al.. (2024). Clinical significance of anti-Epstein–Barr virus antibodies in systemic chronic active Epstein–Barr virus disease. Frontiers in Microbiology. 14. 1320292–1320292. 2 indexed citations
2.
Sawada, Megumi, Naohiko Inase, Yoshio Ohtani, et al.. (2003). Chromosome 9p deletion in squamous metaplasia in cystic lesion of the lung. Respirology. 8(2). 239–242.
3.
Inase, Naohiko, Megumi Sawada, Yoshio Ohtani, et al.. (2003). Cyclosporin A Followed by the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis with Corticosteroid. Internal Medicine. 42(7). 565–570. 69 indexed citations
4.
Miyake, Shuji, Yoshio Ohtani, Megumi Sawada, et al.. (2002). Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis.. PubMed. 19(2). 128–33. 23 indexed citations
5.
Sumi, Yuki, Yoshio Ohtani, Megumi Sawada, et al.. (2001). [A case of Churg-Strauss syndrome in which positive rheumatoid factor and MPO-ANCA preceded the development of clinical symptoms of vasculitis].. PubMed. 39(6). 410–4. 1 indexed citations
6.
Yoshizawa, Yasuyuki, Yuki Sumi, Megumi Sawada, et al.. (2001). Immunological Lung Disease -Recent Advances in the Pathogenesis of Hypersensitivity Pneumonitis.. Internal Medicine. 40(2). 164–167. 5 indexed citations
7.
Ohtani, Yoshio, Kaoru Kojima, Yuki Sumi, et al.. (2000). Inhalation Provocation Tests in Chronic Bird Fancier's Lung. CHEST Journal. 118(5). 1382–1389. 106 indexed citations
8.
Ohtani, Yoshio, et al.. (2000). Acute Intermittent Porphyria Associated with Transient Elevation of Transaminases during an Acute Attack.. Internal Medicine. 39(1). 45–49. 6 indexed citations
9.
Tanaka, Michiko, Megumi Sawada, Naohiko Inase, et al.. (1999). Cases of Gingival Metastasis from Lung Cancer and a Review of the Literature.. Haigan. 39(3). 323–329. 8 indexed citations
10.
Sawada, Megumi, S. Miyake, Shinichi Ohdama, et al.. (1999). Expression of tissue factor in non-small-cell lung cancers and its relationship to metastasis. British Journal of Cancer. 79(3-4). 472–477. 96 indexed citations
11.
Ohtani, Yoshio, Yuki Sumi, Yoshihiro Miyashita, et al.. (1999). Sequential Changes in Bronchoalveolar Lavage Cells and Cytokines in a Patient Progressing from Acute to Chronic Bird Fancier's Lung Disease.. Internal Medicine. 38(11). 896–899. 22 indexed citations
12.
Miyazaki, Yasunari, et al.. (1998). Effects of a Neutrophil Elastase Inhibitor (ONO-5046) on Acute Pulmonary Injury Induced by Tumor Necrosis Factor Alpha (TNF α ) and Activated Neutrophils in Isolated Perfused Rabbit Lungs. American Journal of Respiratory and Critical Care Medicine. 157(1). 89–94. 53 indexed citations
13.
Sawada, Megumi, Susumu Isogai, Shuji Miyake, Tetsuo Kubota, & Yasuyuki Yoshizawa. (1998). Pulmonary Pseudallescherioma Associated with Systemic Lupus Erythematosus.. Internal Medicine. 37(12). 1046–1049. 13 indexed citations
14.
Koyama, Takatoshi, Kenji Nishida, Shinichi Ohdama, et al.. (1994). Determination of plasma tissue factor antigen and its clinical significance. British Journal of Haematology. 87(2). 343–347. 126 indexed citations
15.
Sawada, Megumi, Shinichi Ohdama, Takeshi Umino, et al.. (1994). [Metastasis of an adenocarcinoma of unknown origin to mediastinal lymph nodes, and transient regression].. PubMed. 32(9). 867–72. 2 indexed citations
16.
Takahashi, Shoichi, et al.. (1993). Leukocyte-endothelial interaction: effect of reactive metabolite scavenger.. PubMed. 25(1 Pt 2). 1636–8. 2 indexed citations
17.
Umino, T., Shinichi Ohdama, Megumi Sawada, et al.. (1993). [A case of surgically resected primary pulmonary lymphoma with IgG-paraproteinemia: gene analysis was effective for establishing its diagnosis].. PubMed. 31(8). 1012–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026